Release Date: 09/03/11 15:11 Summary: Listing Rule 3.17 Price Sensitive: No Download Document 1.65MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%